Desmoplastic Small Round Cell Tumor (DSRCT) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
Conditions: Desmoplastic Small Round Cell Tumor; Ewing Sarcoma of Bone or Soft Tissue; Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorInterventions: Drug: vincristine; Drug: doxorubicin; Drug: cyclophosphamide; Drug: ifosfamide; Drug: etoposide; Drug: temozolomide; Drug: temsirolimus; Drug: bevacizumab; Drug: sorafenib; Procedure: surgery; Radiation: radiationSponsors: St. Jude Children's Research Hospital; University of Tennessee Health Science Center; ...
Source: ClinicalTrials.gov - September 16, 2013 Category: Research Source Type: clinical trials

Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1
Condition: SarcomaInterventions: Genetic: DNA analysis; Genetic: RNA analysis; Genetic: gene expression analysis; Genetic: mutation analysis; Genetic: nucleic acid sequencing; Genetic: polymerase chain reaction; Other: laboratory biomarker analysis; Other: pharmacogenomic studiesSponsors: Children's Oncology Group; National Cancer Institute (NCI)Active, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2011 Category: Research Source Type: clinical trials

Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor
Conditions: Advanced Cancers; SarcomaInterventions: Procedure: Hyperthermic Peritoneal Perfusion (HIPEC); Drug: CisplatinSponsor: M.D. Anderson Cancer CenterActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2011 Category: Research Source Type: clinical trials

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
Conditions: Sarcoma; Desmoplastic Small Round Cell Tumor (DSRCT)Intervention: Drug: irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylatorSponsors: Memorial Sloan Kettering Cancer Center; Genentech, Inc.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2010 Category: Research Source Type: clinical trials